Nelson Shu-Sang Yee, M.D., Ph.D., R.Ph.
500 University Drive
Hershey, PA 17033
Patient Services Provided
Clinical Evaluation of Cancer Biomarkers in Digestive Organs
Pancreatic Cancer: Pathogenesis, Biomarkers, and Targets
Regional Editor, Clinical Cancer Drugs
Guest Editor, Current Clinical Pharmacology
Host Editor, Frontiers in Oncology
Director, Clinical Elective in Medical Oncology, Penn State College of Medicine
Director, Acting Internship in Medical Oncology, Penn State College of Medicine
Director, Medicine Clerkship in Medical Oncology, Penn State College of Medicine
Translating discovery in zebrafish pancreatic development to human pancreatic cancer: biomarkers, targets, pathogenesis, and therapeutics.
Zebrafish 2013; 10: 132-146.Yee NS
Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
Advances in Experimental Medicine and Biology 2013; 779: 91-143. Yee NS, Zhou W, Lee M, Yee RK
Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma
Cancer Letters 2012; 318:99-105 Yee NS, Zhou W, Chun SC, Liang I-C, Yee RK
Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer
Biology Open 2012; 1:295-307 Yee NS, Zhou W, Liang I-C
Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer
Disease Models & Mechanisms 2011; 4: 240-254 Show all publications »